ilaprazole has been researched along with voriconazole in 1 studies
| Studies (ilaprazole) | Trials (ilaprazole) | Recent Studies (post-2010) (ilaprazole) | Studies (voriconazole) | Trials (voriconazole) | Recent Studies (post-2010) (voriconazole) |
|---|---|---|---|---|---|
| 53 | 24 | 42 | 4,390 | 219 | 2,678 |
| Protein | Taxonomy | ilaprazole (IC50) | voriconazole (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 8.4 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 8.7 | |
| Cholesterol 24-hydroxylase | Homo sapiens (human) | 0.0345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, XB; Peng, FH; Wang, F; Xiang, DX; Xiao, YW; Xie, XB; Xu, P; Yan, M; Zhang, BK; Zhao, YC | 1 |
1 other study(ies) available for ilaprazole and voriconazole
| Article | Year |
|---|---|
Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobins; Humans; Invasive Fungal Infections; Kidney Transplantation; Male; Pharmacogenomic Variants; Platelet Count; Prospective Studies; Voriconazole | 2021 |